One year ago Elisa Lavelle Wijohn appeared in this paper with six other women who were among those fighting for funding for the life-extending drug Ibrance. All of them had metastatic breast cancer – the kind that can be treated, not cured. They were part of a group that took a petition to Parliament and spoke before a select committee, succeeded in gaining funding for Ibrance and another life-extending drug, Kadcyla.

Today is Metastatic Breast Cancer Awareness Day. Wijohn, a mother of three, is now 14 months into the median survival period of 16 months that New Zealand women are given when diagnosed. She tells her story to help raise awareness of the need to remain vigilant, and why the fight for better funding of medicines in New Zealand needs to go on.

Composing a bucket list what would you choose? Would you read to your children or speak to the news? Would you write notes of love or petitions so pleading? Is it novels or drug requests you'd prefer to be reading? If your time on earth was slipping away Would you chose to have fun, to laugh and to dance Or join others fighting for a fairer chance? Would you slip away quietly into the gentle night Or pick up your sword and with others fight? Would you shrug at injustice when you see others pass Or would you fight so

Advertisement
Advertisement